Maicol Mancini

883 total citations
15 papers, 499 citations indexed

About

Maicol Mancini is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Maicol Mancini has authored 15 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Maicol Mancini's work include HER2/EGFR in Cancer Research (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Advanced Chemical Sensor Technologies (3 papers). Maicol Mancini is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Advanced Chemical Sensor Technologies (3 papers). Maicol Mancini collaborates with scholars based in France, Israel and Italy. Maicol Mancini's co-authors include Yosef Yarden, Michael Sela, Bilha Schechter, Ruth Maron, Yosef Yarden, Moshit Lindzen, Nadège Gaborit, Sara Lavi, Fernando Schmitt and Sílvia Carvalho and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and Biochemical Journal.

In The Last Decade

Maicol Mancini

14 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maicol Mancini France	10	337	211	131	102	70	15	499
Christopher Montemagno France	14	196 0.6×	169 0.8×	105 0.8×	86 0.8×	92 1.3×	31	453
Kian Kani United States	12	245 0.7×	177 0.8×	72 0.5×	87 0.9×	60 0.9×	21	438
Joana M. Senra United Kingdom	8	365 1.1×	240 1.1×	121 0.9×	72 0.7×	227 3.2×	10	600
Hiroaki Fujimori Japan	15	462 1.4×	281 1.3×	70 0.5×	42 0.4×	71 1.0×	25	619
Claudia Capdevila United States	6	175 0.5×	165 0.8×	73 0.6×	55 0.5×	148 2.1×	8	411
Sarwat Naz United States	11	233 0.7×	117 0.6×	93 0.7×	36 0.4×	83 1.2×	14	394
Sei Sai South Korea	12	203 0.6×	137 0.6×	159 1.2×	72 0.7×	128 1.8×	25	492
Priscillia Battiston-Montagne France	12	234 0.7×	136 0.6×	199 1.5×	94 0.9×	133 1.9×	16	477
Marion Gilormini France	5	169 0.5×	138 0.7×	83 0.6×	53 0.5×	93 1.3×	7	329
Song Cho United States	9	221 0.7×	157 0.7×	57 0.4×	56 0.5×	61 0.9×	15	345

Countries citing papers authored by Maicol Mancini

Since Specialization

Citations

This map shows the geographic impact of Maicol Mancini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maicol Mancini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maicol Mancini more than expected).

Fields of papers citing papers by Maicol Mancini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maicol Mancini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maicol Mancini. The network helps show where Maicol Mancini may publish in the future.

Co-authorship network of co-authors of Maicol Mancini

This figure shows the co-authorship network connecting the top 25 collaborators of Maicol Mancini. A scholar is included among the top collaborators of Maicol Mancini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maicol Mancini. Maicol Mancini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Dormont, Laurent, Bruno Buatois, Maxime Hervé, et al.. (2024). Partial role of volatile organic compounds in behavioural responses of mice to bedding from cancer-affected congeners. Biology Open. 13(10).

Dormont, Laurent, Bruno Buatois, Maxime Hervé, et al.. (2023). Urinary VOCs as biomarkers of early stage lung tumour development in mice. Cancer Biomarkers. 39(2). 113–125. 3 indexed citations

Buatois, Bruno, Maxime Hervé, Maicol Mancini, et al.. (2022). Odours of cancerous mouse congeners: detection and attractiveness. Biology Open. 11(4). 5 indexed citations

Mancini, Maicol, Luca Costa, Patrice Lassus, et al.. (2021). MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesis. Scientific Reports. 11(1). 5752–5752. 11 indexed citations

Mancini, Maicol, Laura Papon, Emilie Bousquet, et al.. (2021). Generation and Characterization of a New Preclinical Mouse Model of EGFR-Driven Lung Cancer with MET-Induced Osimertinib Resistance. Cancers. 13(14). 3441–3441. 7 indexed citations

Mancini, Maicol, Laura Papon, Alain Mangé, Florence Cammas, & Eric Fabbrizio. (2020). HP1s modulate the S-Adenosyl Methionine synthesis pathway in liver cancer cells. Biochemical Journal. 477(5). 1033–1047. 5 indexed citations

Monica, Silvia La, Claudia Fumarola, Daniele Cretella, et al.. (2020). Efficacy of the CDK4/6 Dual Inhibitor Abemaciclib in EGFR-Mutated NSCLC Cell Lines with Different Resistance Mechanisms to Osimertinib. Cancers. 13(1). 6–6. 34 indexed citations

Romaniello, Donatella, Luigi Mazzeo, Maicol Mancini, et al.. (2018). A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways. Clinical Cancer Research. 24(22). 5610–5621. 43 indexed citations

Mancini, Maicol, Hilah Gal, Nadège Gaborit, et al.. (2017). An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation EGFR inhibitors. EMBO Molecular Medicine. 10(2). 294–308. 42 indexed citations

10.

Gaborit, Nadège, Ali Abdul‐Hai, Maicol Mancini, et al.. (2015). Examination of HER3 targeting in cancer using monoclonal antibodies. Proceedings of the National Academy of Sciences. 112(3). 839–844. 35 indexed citations

11.

Mancini, Maicol & Yosef Yarden. (2015). Mutational and network level mechanisms underlying resistance to anti-cancer kinase inhibitors. Seminars in Cell and Developmental Biology. 50. 164–176. 27 indexed citations

12.

Kedmi, Merav, Nir Ben‐Chetrit, Cindy Körner, et al.. (2015). EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer. Science Signaling. 8(368). ra29–ra29. 77 indexed citations

13.

Mancini, Maicol, Nadège Gaborit, Moshit Lindzen, et al.. (2015). Combining three antibodies nullifies feedback-mediated resistance to erlotinib in lung cancer. Science Signaling. 8(379). ra53–ra53. 30 indexed citations

14.

Maron, Ruth, et al.. (2013). Inhibition of pancreatic carcinoma by homo- and heterocombinations of antibodies against EGF-receptor and its kin HER2/ErbB-2. Proceedings of the National Academy of Sciences. 110(38). 15389–15394. 37 indexed citations

15.

Maron, Ruth, et al.. (2013). Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth. Proceedings of the National Academy of Sciences. 110(20). 8170–8175. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact